Lamivudine for Solid Tumors

Clinical trial NCT06494579 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06494579
Sponsor: Thomas Marron
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed/Refractory Solid Tumors

Start date: 2024-09-26
Primary completion: 2026-07-28
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.